SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-022786
Filing Date
2020-11-05
Accepted
2020-11-05 16:16:54
Documents
15
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20201104_8k.htm   iXBRL 8-K 26078
2 EXHIBIT 99.1 ex_211999.htm EX-99.1 142064
7 logo.jpg GRAPHIC 5387
  Complete submission text file 0001437749-20-022786.txt   322170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20201105.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20201105_def.xml EX-101.DEF 11586
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20201105_lab.xml EX-101.LAB 15466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20201105_pre.xml EX-101.PRE 11740
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20201104_8k_htm.xml XML 2565
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 201290669
SIC: 2834 Pharmaceutical Preparations